NCT07638436 clinical trial report covering Adebrelimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07637578 clinical trial report covering Tocilizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07639840 clinical trial report covering Roflumilast, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07639086 clinical trial report covering Sacituzumab tirumotecan, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07638722 clinical trial report covering Mosunetuzumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600126556 clinical trial report covering Iparomlimab/Tuvonralimab, Phase 2, endpoints, sponsor, geography, readout timing and development white spac

NCT07639528 clinical trial report covering Futibatinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07640893 clinical trial report covering SR-604, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07643350 clinical trial report covering Anlotinib Dihydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600126558 clinical trial report covering CG-001(ComGen), Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07640932 clinical trial report covering Lurbinectedin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07642453 clinical trial report covering Venetoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.